The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Citi Raises BHP Billiton And Rio Tinto To Buy

Fri, 10th Jul 2015 08:37

LONDON (Alliance News) - The following shares received analyst recommendations Friday morning:
----------
FTSE 100
----------
CITIGROUP RAISES BHP BILLITON TO 'BUY' ('NEUTRAL') - PRICE TARGET 1400 (1500) PENCE
----------
CITIGROUP RAISES RIO TINTO TO 'BUY' - PRICE TARGET 2800 (2950) PENCE
----------
CITIGROUP CUTS RANDGOLD RESOURCES PRICE TARGET TO 4644 (5228) PENCE - 'NEUTRAL'
----------
CITIGROUP CUTS ANTOFAGASTA PRICE TARGET TO 600 (650) PENCE - 'SELL'
----------
EXANE BNP CUTS SMITHS GROUP PRICE TARGET TO 1090 (1125) PENCE - 'NEUTRAL'
----------
DEUTSCHE BANK CUTS BARCLAYS PRICE TARGET TO 287 (305) PENCE - 'BUY'
----------
EXANE BNP CUTS GKN PRICE TARGET TO 370 (380) PENCE - 'NEUTRAL'
----------
SOCGEN CUTS GKN PRICE TARGET TO 355 (400) PENCE - 'HOLD'
----------
DEUTSCHE BANK CUTS GLAXOSMITHKLINE PRICE TARGET TO 1490 (1540) PENCE - 'HOLD'
----------
EXANE BNP CUTS WEIR GROUP PRICE TARGET TO 1800 (1925) PENCE - 'NEUTRAL'
----------
EXANE BNP RAISES AB FOODS PRICE TARGET TO 3500 (3200) PENCE - 'OUTPERFORM'
----------
BERNSTEIN CUTS MARKS & SPENCER PRICE TARGET TO 535 (595) PENCE - MARKET-PERFORM
----------
BARCLAYS RAISES STANDARD LIFE PRICE TARGET TO 546 (520) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES ST JAMES'S PLACE PRICE TARGET TO 1148 (1106) PENCE - OVERWEIGHT
----------
BARCLAYS RAISES RSA INSURANCE PRICE TARGET TO 436 (428) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES LEGAL & GENERAL PRICE TARGET TO 289 (285) PENCE - 'OVERWEIGHT'
----------
BARCLAYS RAISES AVIVA PRICE TARGET TO 637 (632) PENCE - 'OVERWEIGHT'
----------
BARCLAYS RAISES ADMIRAL GROUP PRICE TARGET TO 1572 (1523) PENCE - EQUAL WEIGHT
----------
BARCLAYS RAISES PRUDENTIAL PRICE TARGET TO 1889 (1877) PENCE - 'OVERWEIGHT'
----------
BERENBERG RAISES BAE SYSTEMS TO 'BUY' ('HOLD') - TARGET 570 (530) PENCE
----------
FTSE 250
----------
HSBC CUTS SYNTHOMER PRICE TARGET TO 285 (300) PENCE - 'HOLD'
----------
EXANE BNP CUTS VESUVIUS PRICE TARGET TO 470 (480) PENCE - 'OUTPERFORM'
----------
EXANE BNP CUTS SPECTRIS PRICE TARGET TO 2415 (2500) PENCE - 'OUTPERFORM'
----------
EXANE BNP CUTS ROTORK PRICE TARGET TO 200 (220) PENCE - 'UNDERPERFORM'
----------
DEUTSCHE BANK CUTS DRAX GROUP PRICE TARGET TO 270 (370) PENCE - 'HOLD'
----------
GOLDMAN CUTS DRAX GROUP PRICE TARGET TO 285 (411) PENCE - 'NEUTRAL'
----------
BERNSTEIN CUTS DRAX GROUP PRICE TARGET TO 370 (420) PENCE - 'OUTPERFORM'
----------
EXANE BNP CUTS MELROSE PRICE TARGET TO 285 (310) PENCE - 'OUTPERFORM'
----------
EXANE BNP CUTS IMI PRICE TARGET TO 1050 (1080) PENCE - 'UNDERPERFORM'
----------
EXANE BNP RAISES HALMA PRICE TARGET TO 850 (800) PENCE - 'OUTPERFORM'
----------
SOCGEN CUTS IMI PRICE TARGET TO 1400 (1450) PENCE - 'BUY'
----------
PANMURE RAISES BREWIN DOLPHIN HLDGS PRICE TARGET TO 350 (300) PENCE - 'BUY'
----------
SOCGEN INITIATES CRODA WITH 'BUY' - TARGET 3050 PENCE
----------
CITIGROUP CUTS POLYMETAL PRICE TARGET TO 465 (522) PENCE - 'SELL'
----------
JPMORGAN CUTS ASHMORE GROUP PRICE TARGET TO 265 (275) PENCE - 'UNDERWEIGHT'
----------
GOLDMAN CUTS ASHMORE GROUP PRICE TARGET TO 330 (343) PENCE - 'NEUTRAL'
----------
CITIGROUP CUTS PETRA DIAMONDS PRICE TARGET TO 180 (215) PENCE - 'BUY'
----------
JPMORGAN RAISES HAYS PRICE TARGET TO 155 (145) PENCE - 'NEUTRAL'
----------
UBS CUTS LONMIN TO 'SELL' ('NEUTRAL') - TARGET 75 (130) PENCE
----------
CITIGROUP CUTS LONMIN PRICE TARGET TO 113 (144) PENCE - 'NEUTRAL'
----------
CITIGROUP CUTS KAZ MINERALS PRICE TARGET TO 270 (300) PENCE - 'BUY'
----------
CITIGROUP RAISES ACACIA MINING PRICE TARGET TO 312 (283) PENCE - 'NEUTRAL'
----------
BERENBERG RAISES DIGNITY PRICE TARGET TO 2260 (1850) PENCE - 'HOLD'
----------
UBS RAISES MICRO FOCUS PRICE TARGET TO 1460 (1420) PENCE - 'NEUTRAL'
----------
UBS RAISES HALFORDS GROUP PRICE TARGET TO 530 (485) PENCE - 'NEUTRAL'
----------
UBS RAISES DERWENT LONDON PRICE TARGET TO 3750 (3600) PENCE - 'NEUTRAL'
----------
BARCLAYS RAISES PHOENIX GROUP PRICE TARGET TO 794 (790) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS CUTS LANCASHIRE HLDGS PRICE TARGET TO 456 (463) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS CUTS HISCOX PRICE TARGET TO 607 (620) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS RAISES ESURE GROUP PRICE TARGET TO 300 (288) PENCE - 'OVERWEIGHT'
----------
BARCLAYS CUTS AMLIN PRICE TARGET TO 391 (407) PENCE - 'UNDERWEIGHT'
----------
SOCGEN CUTS ASHMORE GROUP PRICE TARGET TO 325 (350) PENCE - 'BUY'
----------
BERENBERG CUTS BALFOUR BEATTY PRICE TARGET TO 250 (260) PENCE - 'BUY'
----------
MAIN MARKET AND AIM
----------
CITIGROUP CUTS SOUTH32 PRICE TARGET TO 110 (140) PENCE - 'BUY'
----------
CITIGROUP RAISES PETROPAVLOVSK PRICE TARGET TO 6 (5) PENCE - 'SELL'
----------
CITIGROUP CUTS POLYUS GOLD PRICE TARGET TO 185 (194) PENCE - 'NEUTRAL'
----------
CITIGROUP RAISES HOCHSCHILD MINING PRICE TARGET TO 75 (65) PENCE - 'SELL'
----------
CITIGROUP CUTS GEM DIAMONDS PRICE TARGET TO 155 (161) PENCE - 'NEUTRAL'
----------
CITIGROUP RAISES FERREXPO PRICE TARGET TO 38 (31) PENCE - 'SELL'
----------
BARCLAYS RAISES PARTNERSHIP PRICE TARGET TO 117 (111) PENCE - 'UNDERWEIGHT'
----------
BERENBERG CUTS PENDRAGON PRICE TARGET TO 44 (45) PENCE - 'BUY'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.